Thiomersal: implementation of the warning statement relating to sensitisation

  • Email
  • Help
Current version

Position paper

Reference numberEMEA/CHMP/VWP/19541/2007
Published11/01/2007
KeywordsThiomersal, preservative, vaccines, immunoglobulins, antimicrobial, organomercuric, summary of product characteristics (SmPC), sensitisation
DescriptionThis document provides guidance on the wording of the summary of product characterisitics and the package lefleat for the use of thiomersal in medicinal products with regard to sensitisation.

How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more